the edit. review
Fully disclosed care chain
A clinician-led longevity practice that names its management company, its medical group and its pharmacy — and prices the visit into the medication.
Our verdict
The Edit does the thing most compounded-GLP-1 sellers avoid: it tells you exactly who is involved in your care before you pay. The management company, the affiliated medical practice and the dispensing pharmacy are all named on the site, the compounded-versus-branded distinction is spelled out in its own FAQ rather than a footer, and the monthly price includes the provider visit and ongoing care with no membership fee bolted on. It is not the cheapest option on our GLP-1 board, and its NAD+ line at $249/mo is priced well above the field. What you are paying for is transparency and a clean structure, which on this board is genuinely scarce.
Disclosure: Aminoscope is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. This never affects our rankings or verdicts. How we make money.
At a glance
- Category
- GLP-1 telehealth
- Access
- Semaglutide $209/mo, tirzepatide $309/mo after a lower first month; visit and refills included, no membership fee; 50 states
- Medications
- Compounded semaglutide · Compounded tirzepatide
- Insurance
- Cash-pay, no insurance
- Visit
- Quiz intake / Async intake
- Availability
- All 50 states
- Updated
- August 2026
Popular alternative
Enhance MD
Lab-guided treatment under ongoing physician oversight
Check Enhance MD availability →What it is
A clinician-led telehealth practice organized around three lines: weight loss (compounded semaglutide and tirzepatide), energy and longevity (NAD+ and sermorelin), and skin and recovery (glutathione and a GHK-Cu copper-peptide cream). The whole site is published in English and Spanish.
How it works
Asynchronous. You complete an online questionnaire covering health history, goals and current medications; a provider licensed in your state reviews it and decides whether treatment is appropriate. Clinical care is delivered by Arora Health & Aesthetics, LLC, an independent medical practice; The Edit Health LLC is a Texas management services organization that supplies the technology and administration and explicitly does not practice medicine. Prescriptions are filled by The Pharmacy Hub and ship in temperature-controlled two-day packaging. Ongoing care continues through secure messaging in a member portal. The Edit is available in all 50 states.
Pricing transparency
Priced per product per month, with the provider visit, dose adjustments, refills and ongoing care included — there is no separate membership fee, and if a provider does not approve you, you are not charged. Semaglutide is $109 for the first month and $209/mo thereafter; tirzepatide is $209 first month and $309/mo thereafter. Prepay options bring the effective rate down: semaglutide $575 for three months ($192/mo) or $1,065 for six ($178/mo); tirzepatide $855 for three ($285/mo) or $1,575 for six ($263/mo). NAD+ is $249/mo, glutathione $199/mo, sermorelin $169/mo and the GHK-Cu cream $129/mo. We quote the standing rate rather than the introductory one, because the intro price applies to a single month and the ongoing figure is what you will actually pay.
Branded vs compounded
Everything is compounded and labeled as such. The Edit's own FAQ states that semaglutide is the active ingredient in FDA-approved Ozempic and Wegovy and tirzepatide the active ingredient in Mounjaro and Zepbound, and that the compounded versions are "not affiliated with, endorsed by, or a substitute for those products" — clearer than most competitors manage. The site also states that it does not sell research-use-only compounds, which is a meaningful line to hold a peptide seller to. On the evidence behind what it sells: the semaglutide and tirzepatide trial data is strong and applies to the branded products, not to compounded copies of them; sermorelin has a real growth-hormone-axis mechanism but thin long-term outcome data; injected NAD+ has no controlled human outcome trials at all, and the randomized evidence sits with the oral NR/NMN precursors, where the endpoint reached is a raised blood level rather than a clinical benefit; GHK-Cu has essentially no controlled human outcome data for the claims usually made.
Pros and watch-outs
What we like
- Names all three parties in the care chain — management company, medical practice and dispensing pharmacy
- The provider visit and ongoing care are included in the medication price, with no membership fee
- No charge at all if a provider declines to treat you
- Compounded-versus-branded disclosure is stated in the FAQ, not buried in a footer
- Available in all 50 states, with the entire site published in Spanish as well as English
- States outright that it does not sell research-use-only compounds
Watch-outs
- More expensive than most of this board — $209 semaglutide and $309 tirzepatide are mid-to-high, and $249 NAD+ is high
- The advertised first-month price ($109 / $209) is roughly half the standing rate, so the headline understates the ongoing cost
- Fully asynchronous — no video visit is offered at any tier
- No LegitScript certification is claimed anywhere on the site
- Shares its medical group, Arora Health & Aesthetics, with Trellis Vitality, and its platform with two other providers on this board
Best for
Buyers who want to know exactly which practice and which pharmacy are behind their prescription before they pay, and who would rather have the visit priced into the medication than added as a membership fee.
Who should look elsewhere
Price-driven buyers — several providers on this board sell the same compounded molecules for meaningfully less — or anyone who wants a live video consultation or a LegitScript-certified seller.
The evidence behind what the edit. prescribes
We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.
- What the semaglutide weight-loss trials actually showed
STEP 1, STEP 4, and SELECT — the efficacy, the rebound, and the cardiovascular signal, read straight from the primary literature.
- Tirzepatide vs semaglutide for weight loss: what the trials actually support
Most comparisons are cross-trial. Only SURPASS-2 and SURMOUNT-5 randomized one drug against the other — here's the precise distinction.
- Sermorelin: a real GHRH drug, read against the anti-aging pitch
An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.
- NAD+ precursors (NR and NMN): what the human trials actually show
They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.
- GHK-Cu: the copper peptide between real skincare and overclaim
A decades-deep molecule with a credible topical story — and systemic anti-aging claims that outrun the human data.
- Glutathione: the master antioxidant, and where the evidence actually is
Oral glutathione really does raise your body stores (a 6-month RCT proved it) — but the longevity and detox claims are unproven, skin-lightening is modest, and IV glutathione is the most marketed, least evidenced route. The precursors may be the smarter bet.
How the edit. compares
A few alternatives worth a look, depending on what you’re optimizing for.
Trellis VitalityBuyers who want one flat GLP-1 price at every dose, from a named pharmacy
See Trellis Vitality →
AurenRxBuyers who want a named pharmacy and will read past the advertised headline price
See AurenRx →
VyvronBuyers comparing microdose GLP-1 options who will price off the intake, not the banner
See Vyvron →
Access & cost · Reviewed and last verified August 2026
How we assessed this. This review reflects Aminoscope’s own read of the edit.’s publicly-stated model — pricing transparency, clinical oversight, medication clarity, and access — against our editorial methodology. We publish no fabricated ratings or first-hand outcomes. A partnership never changes the assessment — see how we make money.
Frequently asked
- Who actually prescribes and dispenses for The Edit?
- Clinical care comes from licensed providers at Arora Health & Aesthetics, LLC, an independent medical practice. The Edit Health LLC is a Texas management services organization that supplies the technology and administration and does not practice medicine. Prescriptions are filled by The Pharmacy Hub, a licensed U.S. pharmacy, and shipped to you directly.
- Is the $109 semaglutide price the ongoing rate?
- No. $109 covers your first month; the standing rate is $209/mo. Tirzepatide follows the same pattern at $209 first month and $309/mo after. If you prepay, the effective rate falls — $1,065 for six months of semaglutide works out to $178/mo.
- Is The Edit's semaglutide the same as Ozempic or Wegovy?
- No, and The Edit says so itself. Its products are compounded preparations of the same active ingredient, not the branded drugs. Compounded medications are not reviewed by the FDA for safety, effectiveness or quality before they are sold, and are not a substitute for the approved products.
- Does the price include the consultation?
- Yes. Each monthly price covers the provider review, your prescription if one is appropriate, ongoing dose adjustments and refills. There is no separate membership fee, and you are not charged at all if you are not approved for treatment.
- Is The Edit available in my state?
- The Edit says it operates in all 50 states through affiliated providers and pharmacy partners licensed in each jurisdiction. Availability for your specific address and treatment is confirmed during the consultation.